Hypertension Clinical Trials

Find Hypertension Clinical Trials Near You

Optical Coherence Tomography Angiography (OCTA) for the Assessment of Retinal Capillary Density in Patients With Cardiovascular Disease and a Healthy Control Group

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:

• cardiovascular disease defined as one or more of the following: arterial hypertension, type 2 diabetes mellitus, chronic kidney disease, heart failure

• BMI 18-29.9 kg/m2

• Non-smoker

• Good general health, as determined by study personnel based on assessments of previous visits, including anamnesis, vital signs, physical examination and clinical laboratory parameters.

Locations
Other Locations
Germany
University of Erlangen Nuremberg
RECRUITING
Erlangen
Contact Information
Primary
Agnes Bosch, MD
agnes.bosch@uk-erlangen.de
+49 9131 8536245
Backup
Dennis Kannenkeril, MD
CRC.M4@uk-erlangen.de
+49 911 80099760
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2027-03
Participants
Target number of participants: 64
Treatments
Other: Assessment of retinal vessels
OCTA and SLDF based assessment of retinal vasculature
Related Therapeutic Areas
Sponsors
Collaborators: German Diabetes Association
Leads: University of Erlangen-Nürnberg Medical School

This content was sourced from clinicaltrials.gov